Robert E. Gerszten

46.8k total citations · 11 hit papers
237 papers, 22.9k citations indexed

About

Robert E. Gerszten is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert E. Gerszten has authored 237 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Molecular Biology, 65 papers in Physiology and 53 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert E. Gerszten's work include Metabolomics and Mass Spectrometry Studies (71 papers), Diet and metabolism studies (35 papers) and Adipose Tissue and Metabolism (28 papers). Robert E. Gerszten is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (71 papers), Diet and metabolism studies (35 papers) and Adipose Tissue and Metabolism (28 papers). Robert E. Gerszten collaborates with scholars based in United States, Canada and Sweden. Robert E. Gerszten's co-authors include Thomas J. Wang, Clary B. Clish, Gregory D. Lewis, Eugene P. Rhee, Ramachandran S. Vasan, Ru Wei, Martin G. Larson, Heather R. Christofk, Mark D. Fleming and Matthew G. Vander Heiden and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert E. Gerszten

226 papers receiving 22.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolite profiles and the risk of developing diabetes

2011 2.3k citations Thomas J. Wang, Ramachandran S. Vasan et al. profile →
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

2008 2.2k citations Robert E. Gerszten et al. profile →
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

1999 1.0k citations Robert E. Gerszten et al. profile →
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

2010 780 citations S. Hani Najafi‐Shoushtari, Fjoralba Kristo et al. Science profile →
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

2013 699 citations Robert E. Gerszten et al. profile →
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

2012 573 citations Robert E. Gerszten et al. profile →
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

2011 481 citations Gregory D. Lewis, Steven A. Carr et al. profile →
Targeted Metabolomics

2012 476 citations Robert E. Gerszten, Clary B. Clish et al. profile →
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

2011 476 citations Robert E. Gerszten et al. The American Journal of Cardiology profile →
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab

2013 398 citations Robert E. Gerszten et al. profile →
Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease

2020 186 citations Jonathan D. Mosley, Bruce M. Psaty et al. profile →

Peers

Countries citing papers authored by Robert E. Gerszten

Since Specialization

Citations

This map shows the geographic impact of Robert E. Gerszten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Gerszten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Gerszten more than expected).

Fields of papers citing papers by Robert E. Gerszten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Gerszten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Gerszten. The network helps show where Robert E. Gerszten may publish in the future.

Co-authorship network of co-authors of Robert E. Gerszten

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Gerszten. A scholar is included among the top collaborators of Robert E. Gerszten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Gerszten. Robert E. Gerszten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation between Olink and SomaScan proteomics platforms in adults with a Fontan circulation 2025 ·International Journal of Cardiology Congenital Heart Disease ·(unknown), Michael J. Landzberg, (unknown), Renaud David, (unknown), (unknown), (unknown), Miriam Michel, Robert E. Gerszten, Alexander R. Opotowsky	1
2	Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death 2024 ·Circulation Genomic and Precision Medicine ·ThuyVy Duong, Thomas R. Austin, Jennifer A. Brody, Ali Shojaie, Alexis Battle, Joel S. Bader, Yun Soo Hong, Christie M. Ballantyne, Josef Coresh, Robert E. Gerszten, Russell P. Tracy, Bruce M. Psaty, Nona Sotoodehnia, Dan E. Arking	0
3	Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea 2024 ·Circulation Heart Failure ·(unknown), Elizabeth Liu, Jessica K. Wang, L. Daniel Myers, (unknown), (unknown), Gregory D. Lewis, Rajeev Malhotra, Matthew Nayor, Jeremy Robbins, Robert E. Gerszten, Naomi M. Hamburg, Jenna McNeill, Emily S. Lau, Jennifer E. Ho	18
4	Proteomics, Human Environmental Exposure, and Cardiometabolic Risk 2024 ·Circulation Research ·Andrew Perry, Kai Zhang, Venkatesh L. Murthy, Bina Choi, Shilin Zhao, (unknown), Laura A. Colangelo, Lifang Hou, Mary B. Rice, J. Jeffrey Carr, April P. Carson, Anne E. Nigra, Ramachandran S. Vasan, Robert E. Gerszten, Sadiya S. Khan, Ravi Kalhan, Matthew Nayor, Ravi V. Shah	7
5	Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome 2023 ·Human Molecular Genetics ·Suya Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Haiyan Wu, Xu Yang, Xu Shi, Douglas Strathdee, Robert E. Gerszten, Michael Schlame, William T. Pu	10
6	Omics-driven investigation of the biology underlying intrinsic submaximal working capacity and its trainability 2023 ·Physiological Genomics ·(unknown), Jacob L. Barber, (unknown), (unknown), (unknown), Prashant Rao, Michael Mi, Daniel H. Katz, Jeremy Robbins, Clary B. Clish, Robert E. Gerszten, Mark A. Sarzynski, Sujoy Ghosh, Claude Bouchard	4
7	Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits 2023 ·Journal of Lipid Research ·(unknown), Yan Chen, (unknown), Jacob L. Barber, (unknown), (unknown), (unknown), Bridget Armstrong, Robert E. Gerszten, Günther Silbernagel, Robert J. Konrad, Claude Bouchard, Mark A. Sarzynski	7
8	Genetic Architecture of Plasma Alpha‐Aminoadipic Acid Reveals a Relationship With High‐Density Lipoprotein Cholesterol 2022 ·Journal of the American Heart Association ·Mingjian Shi, Chuan Wang, Hao Mei, Marinella Temprosa, José C. Florez, Mark Tripputi, Jordi Merino, Loren Lipworth, Xiao‐Ou Shu, Robert E. Gerszten, Thomas J. Wang, Joshua A. Beckman, Jorge Gamboa, Jonathan D. Mosley, Jane F. Ferguson	10
9	Plasma metabolomic signatures of obesity and risk of type 2 diabetes 2022 ·Obesity ·Xiong‐Fei Pan, Zsu‐Zsu Chen, Thomas J. Wang, Xiang Shu, Hui Cai, Qiuyin Cai, Clary B. Clish, Xu Shi, Wei Zheng, Robert E. Gerszten, Xiao‐Ou Shu, Danxia Yu	8
10	MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury 2021 ·Circulation Research ·Christian U. Oeing, (unknown), Sumita Mishra, Brittany Dunkerly‐Eyring, Anna Chen, (unknown), Usman A. Tahir, Robert E. Gerszten, Nazareno Paolocci, Mark J. Ranek, David A. Kass	29
11	Human plasma proteomic profiles indicative of cardiorespiratory fitness 2021 ·Nature Metabolism ·Jeremy Robbins, Bennet Peterson, Daniela Schranner, Usman A. Tahir, Theresa Rienmüller, Shuliang Deng, Michelle J. Keyes, Daniel H. Katz, Pierre M. Jean Beltran, Jacob L. Barber, Christian Baumgärtner, Steven A. Carr, Sujoy Ghosh, Changyu Shen, Lori L. Jennings, Robert Ross, Mark A. Sarzynski, Claude Bouchard, Robert E. Gerszten	41
12	Regular exercise and patterns of response across multiple cardiometabolic traits: the HERITAGE family study 2021 ·British Journal of Sports Medicine ·Jacob L. Barber, (unknown), Jeremy Robbins, Robert E. Gerszten, Arthur S. Leon, D. C. Rao, James S. Skinner, Claude Bouchard, Mark A. Sarzynski	14
13	Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement 2021 ·Circulation Cardiovascular Quality and Outcomes ·Jordan B. Strom, Jiaman Xu, Ariela R. Orkaby, Changyu Shen, Yang Song, Brian Charest, Dae Hyun Kim, David J. Cohen, Daniel B. Kramer, John A. Spertus, Robert E. Gerszten, Robert W. Yeh	17
14	Amino Acid Signatures to Evaluate the Beneficial Effects of Weight Loss 2017 ·International Journal of Endocrinology ·(unknown), Martin Magnusson, Anders P. H. Danielsson, Robert E. Gerszten, Thomas J. Wang, Lovisa E. Reinius, Hindrik Mulder, Olle Melander, Martin Ridderstråle	26
15	Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study) 2016 ·The American Journal of Cardiology ·Darae Ko, Eric M. Riles, (unknown), Jared W. Magnani, Steven A. Lubitz, Honghuang Lin, Michelle T. Long, Renate B. Schnabel, David D. McManus, Patrick T. Ellinor, Ramachandran S. Vasan, Thomas J. Wang, Robert E. Gerszten, Emelia J. Benjamin, Xiaoyan Yin, Michiel Rienstra	23
16	Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol Are Associated With Monocytosis and Atherosclerosis 2013 ·Circulation ·Anjali Ganda, Martin Magnusson, Laurent Yvan‐Charvet, Bo Hedblad, Gunnar Engström, Ding Ai, Thomas J. Wang, Robert E. Gerszten, Olle Melander, Alan R. Tall	52
17	Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents 2012 ·Pediatric Obesity ·S. E. McCormack, Ohad Shaham, M.A. McCarthy, Amy Deik, Thomas J. Wang, Robert E. Gerszten, Clary B. Clish, Vamsi K. Mootha, Steven Grinspoon, Amy Fleischman	348
18	A diabetes-predictive amino acid score and future cardiovascular disease 2012 ·European Heart Journal ·Martin Magnusson, Gregory D. Lewis, Ulrika Ericson, Marju Orho‐Melander, Bo Hedblad, Gunnar Engström, Gerd Östling, Clary B. Clish, Thomas J. Wang, Robert E. Gerszten, Olle Melander	219
19	MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis breakdown → 2010 ·Science ·S. Hani Najafi‐Shoushtari, Fjoralba Kristo, Yingxia Li, Toshi Shioda, David E. Cohen, Robert E. Gerszten, Anders M. Näär	780
20	α-Actinin-4 Is Required for Normal Podocyte Adhesion 2006 ·Journal of Biological Chemistry ·Savita Dandapani, Hikaru Sugimoto, Benjamin D. Matthews, Robert J. Kolb, Sumita Sinha, Robert E. Gerszten, Jing Zhou, Donald E. Ingber, Raghu Kalluri, Martin R. Pollak	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact